Does a one-time data license raise a portfolio company's ASC 820 mark?

The short answer for portfolio CFOs

A one-time data license usually adds to a portfolio company's cash, not to the multiple-based value at the heart of its ASC 820 mark. ASC 820 frames fair value as an exit price: the price that would be received to sell the investment in an orderly transaction between market participants at the measurement date. The standard does not pick the method; the sponsor's written valuation policy and its auditors do. Valuation teams commonly estimate it by applying market multiples to normalized earnings, and a single license payment is exactly the kind of item they tend to normalize out.

The practical result: if the payment stays in the company, it reduces net debt in the bridge from enterprise value to equity value, so the equity mark can rise by roughly the cash retained after costs and taxes. If the company sends the cash up to the fund, it shows as a realized distribution instead. What it rarely does is raise the run-rate EBITDA that the multiple is applied to.

How is a quarterly mark usually built?

A quarterly mark is a model-based estimate of fair value, built in five steps. "Mark to market" is the informal phrase, but a private company has no quoted price to mark against.

1. Choose the approach. Many sponsors use a market approach based on multiples of comparable public companies or transactions, often cross-checked with a discounted cash flow.
2. Normalize earnings. The team starts from last-twelve-month or forward EBITDA and adjusts for items it judges non-recurring, such as one-time gains, litigation costs or a single license payment.
3. Apply and calibrate the multiple. The multiple is tied back to the entry price and moved with market evidence.
4. Bridge to equity. Enterprise value less net debt and other claims gives the equity value attributable to the fund.
5. Review and test. The valuation committee approves the mark each quarter, and the fund's auditors test methodology and inputs at year-end.

Your sponsor's written valuation policy sets the details, and it may differ from this outline.

How do valuation teams commonly treat a one-time license?

On the last row: one license shows that the records had value to a buyer, but it is not evidence of a recurring revenue stream. Treating it as one is how a valuation memo drifts into overstatement, the problem covered in the guide to AI washing and how PE firms describe AI initiatives.

How does the company book the license first?

Before the valuation team sees anything, the company's own accounts must record the license under ASC 606. Deloitte's ASC 606 roadmap chapter on the nature of a license explains the key distinction: a right to use intellectual property as it exists when the license is granted is recognized at a point in time, while a right to access it throughout the license period is recognized over time. The structure of a specific data license decides which applies, so agree the treatment with the company's auditors before the quarter closes.

What to bring to the valuation committee

• Status: signed, invoiced or paid, with dates.
• Gross amount, related costs and net cash retained.
• Proposed adjusted EBITDA treatment and the reasoning behind it.
• Effect on net debt and on lender covenant definitions.
• Exclusivity scope and term.
• Confirmation that the forecast assumes no further licenses.

What this means for sponsors and referral partners

For a sponsor, the case for a license is cash and evidence of asset value, not a higher multiple. That framing suits an opt-in portfolio program, where each company's leadership decides whether a one-time payment justifies the work. The company keeps ownership of its data, and nothing is binding until it agrees price and terms and signs.

If someone at the firm introduced the company as a SourceX partner, the reward does not change the company's numbers. Partners earn 25% of the eligible platform fees SourceX actually collects from the referred company's licensing deals, capped at $100,000 per referred company, and the reward becomes payable only after the buyer pays and SourceX receives its fee. It is a share of SourceX's fee, so it is never deducted from what the company receives. Whether it offsets management fees is a fund-level question, covered in fund CFO responsibilities.

Limits and open questions

Practice varies by sponsor. A company that builds a repeatable licensing program with several contracted buyers might be valued differently, and that judgment belongs to the sponsor's valuation advisers and auditors. Credit agreements also define EBITDA in their own terms, which may not match the valuation team's adjustments.

This is general information, not legal, tax or financial advice. Confirm the treatment with your auditors and valuation advisers before acting. This page paraphrases the standard in general terms; the FASB Codification text governs.

Next step

Check a candidate company against the baseline on the who qualifies page, list other candidates with the network opportunity finder, and register as a partner to make the introduction.